Upgrade to SI Premium - Free Trial

ViiV Healthcare Gains CHMP Positive Opinion for Juluca in Europe (GSK) (PFE)

March 23, 2018 7:28 AM
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline (NYSE: GSK), with Pfizer Inc. (NYSE: PFE) and Shionogi ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles